ACBRD

Search Icon

Menu Toggle Icon

Skip to content
  • About Us
    • What We Do
    • Meet the Team
    • In the Media
      • Media appearances
      • Press releases
    • Awards and Recognition
    • Gallery
    • Annual Reports
  • Research
    • Publications
      • Journal Articles
      • Book Chapters
      • Community Publications
      • Reports
    • Presentations
      • Invited Presentations
      • Peer-Reviewed Presentations
    • Themes
    • Events
    • Take Part in Research
    • PhD Opportunities
    • ACBRD Webinar Series
  • Resources
    • For People with Diabetes
    • For Health Professionals
    • Scales & Measures
    • E-Newsletter
  • Blog
  • Contact Us
    • Request an Expert
    • Work with Us
    • Support Us

Tag: Diabetes REmission Clinical Trial

Experiences of a type 2 diabetes remission intervention

Experiences of a type 2 diabetes remission intervention

October 29, 2021February 10, 2022ACBRD

Recent research has shown that type 2 diabetes remission may be possible for some people. We take a look at a study that looks at people’s experiences of the The Diabetes REmission Clinical Trial. 

By Amelia Williams

Read more →
Intervention, Type 2 diabetes, weight Diabetes REmission Clinical Trial, Diabetic Medicine, T2D

Blog Topics

Adolescents Awards Behaviour change Clinical practice Conference COVID-19 depression Diabetes and Emotional Health practical guide Diabetes distress Diabetes MILES Diabetes self-management Diabetic Medicine Driving Education Emotional health Family Gestational Diabetes Glucose monitoring glucose variability Healthcare hypoglycaemia Intervention Language mental health Other Peer support Personality Pregnancy Psychological insulin resistance Quality of life retinopathy Satisfaction self-compassion Stigma Technologies Type 1 diabetes Type 2 diabetes weight

Contact us

Wurundjeri Woi-wurrung Country
Suite G01, 15-31 Pelham Street
Carlton VIC 3053

+61 3 9244 6448

Stay up to date with the ACBRD

Subscribe to our e-newsletter
facebook-circular-logo   twitter   linkedin

Scroll to Top
 

Loading Comments...